The evolving treatment paradigm of lung cancer in China
Main Authors: | Wei Xie, Shuanghuan Liu, Guanqiao Li, Huiyan Xu, Liyun Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Acta Pharmaceutica Sinica B |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522000235 |
Similar Items
-
Psychodermatology: An evolving paradigm
by: Swapna Bondade, et al.
Published: (2022-01-01) -
Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022
by: Zishuo Ian Hu, et al.
Published: (2022-02-01) -
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm
by: Charlie Yang, et al.
Published: (2023-06-01) -
Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer
by: Jingsong Zhang
Published: (2014-06-01) -
Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms
by: Giammarco Mocci, et al.
Published: (2024-03-01)